Sichuan Prius Biotechnology Co., Ltd., founded in 2010, covers an area of 130 mu and has 470 employees. It is a national high-tech enterprise specializing in research, development, production, sales and service of medical polymer and biomaterial products. The company's main products include indwelling needles, infusion sets, syringes, medical masks, protective clothing, etc. It has obtained 26 Class II and Class III product registration certificates, and currently more than 10 products are applying for registration with the National Drug Administration.

Since its establishment, the company has always adhered to the mode of independent innovation and combination of production, teaching and research, and established cooperative relations with CAE Member, Sichuan University, Provincial Testing Institute, etc. The company's technical team is strong and has comprehensive technical research and development capabilities. The main research and development products include implantable infusion devices - infusion ports, central venous catheters inserted through peripheral veins, medium and long catheters/midline catheters, and long-term and continuous research and development of new products and technologies. Currently, the company has 53 patents, including 4 invention patents, and more than 10 new patents are declared every year. The company has made continuous progress in technology research and development, achievement transformation, product design, and other aspects. The independently developed global first "disposable precision filtering and light proof bag infusion set (with needle)" product has passed the evaluation of scientific and technological achievements in Sichuan Province. The evaluation conclusion is that this technology is at the leading level in China. Since its establishment, the company has received honors such as "National High tech Enterprise", "Sichuan Famous Brand Product", "Provincial Enterprise Technology Center", and "Excellent Enterprise for the Year 2018-2021"; And because of its outstanding contributions during the epidemic, it was rated as "Advanced Grass roots Party Organization in Sichuan Province" and "Advanced Collective in Fighting COVID-19 in Sichuan Province" by Sichuan Provincial Party Committee and Government.

With the establishment of the Sichuan Medical Health Emergency Industry Base in the Nanxi Economic Development Zone, the company's development has ushered in new opportunities. Currently, an intelligent manufacturing workshop of 56000 square meters and supporting facilities such as a research and development, training, and exhibition center of 10000 square meters are being constructed, and 16 production lines for Class III medical devices and 13 production lines for Class II medical devices will be added. After the completion of the project, the company will achieve production automation and digital management, establish a production database (blockchain), improve production efficiency and product quality, and automatically record data during the production process to ensure the stability of product quality. It can also achieve visualization of the production process, which is a major innovation in the domestic medical device field; The company will simultaneously achieve an annual output value of 500 to 2 billion yuan, striving to achieve the development direction of the top ten short-term goals, the top eight medium-term goals, and the top five long-term goals in the same industry in China.

In the future, the company will continue to adhere to the business philosophy of "creating high-quality products and serving health", and strive to create high cost performance products that are "the best in quality at the same price, and the best in price at the same quality". We will reduce medical insurance costs and allow consumers to enjoy the highest quality medical device products. We will make "ensuring public health" our lifelong goal, Make greater contributions to the development of healthcare and the improvement of people's health standards!

corporate culture